Media
Megna Health Announces FDA Emergency Authorization of Rapid COVID-19 Antibody IgM/IgG Test Kit
Megna Health, a medical technology company focused on the development and manufacturing of diagnostic and healthcare products, announced today that the Company has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Rapid COVID-19 IgG and IgM Combo Test Kit. Serology testing for COVID-19 Read more…